CONCLUSION:: The multimodality treatment of stage III and IVA thymomas by means of neoadjuvant chemotherapy provides good long-term outcomes in both stages of the disease.

• ：用新辅助化疗的方法治疗III期和IVA期胸腺瘤，为这两期患者的治疗提供了良好的长期的预后。